Literature DB >> 24745331

Sepsis: current dogma and new perspectives.

Clifford S Deutschman1, Kevin J Tracey2.   

Abstract

Sepsis, a clinical syndrome occurring in patients following infection or injury, is a leading cause of morbidity and mortality worldwide. Current immunological mechanisms do not explain the basis of cellular dysfunction and organ failure, the ultimate cause of death. Here we review current dogma and argue that it is time to delineate novel immunometabolic and neurophysiological mechanisms underlying the altered cellular bioenergetics and failure of epithelial and endothelial barriers that produce organ dysfunction and death. These mechanisms might hold the key to future therapeutic strategies.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24745331     DOI: 10.1016/j.immuni.2014.04.001

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  223 in total

1.  Bacterial sepsis triggers an antiviral response that causes translation shutdown.

Authors:  Takashi Hato; Bernhard Maier; Farooq Syed; Jered Myslinski; Amy Zollman; Zoya Plotkin; Michael T Eadon; Pierre C Dagher
Journal:  J Clin Invest       Date:  2018-12-03       Impact factor: 14.808

2.  Zinc dyshomeostasis during polymicrobial sepsis in mice involves zinc transporter Zip14 and can be overcome by zinc supplementation.

Authors:  Inga Wessels; Robert J Cousins
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-08-13       Impact factor: 4.052

3.  TAT-HSP70 Attenuates Experimental Lung Injury.

Authors:  M Melanie Lyons; Nichelle N Raj; Jesse L Chittams; Laurie Kilpatrick; Clifford S Deutschman
Journal:  Shock       Date:  2015-06       Impact factor: 3.454

4.  Loss of CMAH during Human Evolution Primed the Monocyte-Macrophage Lineage toward a More Inflammatory and Phagocytic State.

Authors:  Jonathan J Okerblom; Flavio Schwarz; Josh Olson; William Fletes; Syed Raza Ali; Paul T Martin; Christopher K Glass; Victor Nizet; Ajit Varki
Journal:  J Immunol       Date:  2017-02-01       Impact factor: 5.422

5.  Live-cell visualization of gasdermin D-driven pyroptotic cell death.

Authors:  Joseph K Rathkey; Bryan L Benson; Steven M Chirieleison; Jie Yang; Tsan S Xiao; George R Dubyak; Alex Y Huang; Derek W Abbott
Journal:  J Biol Chem       Date:  2017-07-18       Impact factor: 5.157

6.  A novel PINK1- and PARK2-dependent protective neuroimmune pathway in lethal sepsis.

Authors:  Rui Kang; Ling Zeng; Yangchun Xie; Zhengwen Yan; Borong Zhou; Lizhi Cao; Daniel J Klionsky; Kevin J Tracey; Jianhua Li; Haichao Wang; Timothy R Billiar; Jianxin Jiang; Daolin Tang
Journal:  Autophagy       Date:  2016-10-18       Impact factor: 16.016

7.  Interleukin-3 amplifies acute inflammation and is a potential therapeutic target in sepsis.

Authors:  Georg F Weber; Benjamin G Chousterman; Shun He; Ashley M Fenn; Manfred Nairz; Atsushi Anzai; Thorsten Brenner; Florian Uhle; Yoshiko Iwamoto; Clinton S Robbins; Lorette Noiret; Sarah L Maier; Tina Zönnchen; Nuh N Rahbari; Sebastian Schölch; Anne Klotzsche-von Ameln; Triantafyllos Chavakis; Jürgen Weitz; Stefan Hofer; Markus A Weigand; Matthias Nahrendorf; Ralph Weissleder; Filip K Swirski
Journal:  Science       Date:  2015-03-13       Impact factor: 47.728

Review 8.  The immunopathology of sepsis and potential therapeutic targets.

Authors:  Tom van der Poll; Frank L van de Veerdonk; Brendon P Scicluna; Mihai G Netea
Journal:  Nat Rev Immunol       Date:  2017-04-24       Impact factor: 53.106

9.  Runt-related Transcription Factor 1 (RUNX1) Binds to p50 in Macrophages and Enhances TLR4-triggered Inflammation and Septic Shock.

Authors:  Mao-Cai Luo; Si-Yuan Zhou; Dan-Ying Feng; Jun Xiao; Wei-Yun Li; Chun-Di Xu; Hong-Yan Wang; Tong Zhou
Journal:  J Biol Chem       Date:  2016-08-29       Impact factor: 5.157

10.  Potentiation and tolerance of toll-like receptor priming in human endothelial cells.

Authors:  Stephen R Koch; Fred S Lamb; Judith Hellman; Edward R Sherwood; Ryan J Stark
Journal:  Transl Res       Date:  2016-08-08       Impact factor: 7.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.